Clinical Trial Update: Efficacy of Autologous Outer-Root-Sheath Melanocytes Transplantation in the Treatment of Vitiligo [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating autologous outer-root-sheath melanocyte transplantation for vitiligo has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• Autologous outer-root-sheath melanocytes transplantation

Snippet

Sponsor: Centro Studi Gised | Conditions: Vitiligo | Phase 2 | Status: TERMINATED